tiprankstipranks
Trending News
More News >
Beauty Health (SKIN)
NASDAQ:SKIN
US Market

Beauty Health (SKIN) Ratios

Compare
296 Followers

Beauty Health Ratios

SKIN's free cash flow for Q4 2025 was $0.64. For the 2025 fiscal year, SKIN's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.66 1.66 7.00 6.07 10.92
Quick Ratio
1.40 1.40 5.99 5.28 9.39
Cash Ratio
1.25 1.25 5.43 4.55 7.92
Solvency Ratio
0.04 0.03 <0.01 -0.08 0.08
Operating Cash Flow Ratio
0.20 0.20 0.24 0.19 -1.49
Short-Term Operating Cash Flow Coverage
0.29 0.29 0.00 0.00 0.00
Net Current Asset Value
$ -129.20M$ -129.20M$ -156.76M$ -171.47M$ -52.76M
Leverage Ratios
Debt-to-Assets Ratio
0.76 0.76 0.83 0.81 0.75
Debt-to-Equity Ratio
6.20 6.20 10.97 12.67 4.50
Debt-to-Capital Ratio
0.86 0.86 0.92 0.93 0.82
Long-Term Debt-to-Capital Ratio
0.80 0.80 0.91 0.93 0.81
Financial Leverage Ratio
8.18 8.18 13.24 15.64 6.00
Debt Service Coverage Ratio
0.23 -0.02 1.04 -3.79 6.01
Interest Coverage Ratio
-1.07 -1.08 -6.51 -9.59 -1.93
Debt to Market Cap
2.49 2.10 2.80 1.80 0.55
Interest Debt Per Share
3.12 3.15 4.67 5.82 5.19
Net Debt to EBITDA
3.91 4.42K 19.16 -4.28 2.25
Profitability Margins
Gross Profit Margin
65.26%65.29%54.53%38.97%68.00%
EBIT Margin
4.00%-6.92%-5.72%-22.17%16.05%
EBITDA Margin
12.41%0.01%3.09%-13.46%22.30%
Operating Profit Margin
-6.90%-6.91%-20.27%-32.89%-7.06%
Pretax Profit Margin
-1.97%-1.97%-8.84%-25.60%12.39%
Net Profit Margin
-3.16%-3.16%-8.70%-25.16%12.09%
Continuous Operations Profit Margin
-3.16%-3.16%-8.70%-25.16%12.09%
Net Income Per EBT
160.46%159.99%98.47%98.26%97.54%
EBT Per EBIT
28.56%28.55%43.60%77.83%-175.45%
Return on Assets (ROA)
-1.90%-1.90%-4.24%-10.78%4.41%
Return on Equity (ROE)
-15.42%-15.55%-56.17%-168.57%26.47%
Return on Capital Employed (ROCE)
-6.62%-6.63%-10.97%-16.08%-2.77%
Return on Invested Capital (ROIC)
-4.69%-4.70%-10.72%-15.71%-2.69%
Return on Tangible Assets
-2.82%-2.82%-5.65%-13.51%5.31%
Earnings Yield
-6.44%-5.41%-14.78%-24.45%3.29%
Efficiency Ratios
Receivables Turnover
12.84 12.83 11.75 7.23 4.70
Payables Turnover
6.70 6.69 6.93 5.43 4.11
Inventory Turnover
2.18 2.17 2.20 2.66 1.07
Fixed Asset Turnover
21.33 21.33 17.08 15.11 10.82
Asset Turnover
0.60 0.60 0.49 0.43 0.36
Working Capital Turnover Ratio
1.63 1.13 0.67 0.61 0.45
Cash Conversion Cycle
141.61 141.72 144.35 120.43 330.66
Days of Sales Outstanding
28.44 28.44 31.08 50.47 77.59
Days of Inventory Outstanding
167.66 167.82 165.96 137.24 341.81
Days of Payables Outstanding
54.49 54.54 52.69 67.28 88.73
Operating Cycle
196.10 196.26 197.04 187.71 419.39
Cash Flow Ratios
Operating Cash Flow Per Share
0.29 0.30 0.13 0.17 -0.72
Free Cash Flow Per Share
0.29 0.29 0.08 0.07 -0.84
CapEx Per Share
<0.01 <0.01 0.05 0.10 0.12
Free Cash Flow to Operating Cash Flow
0.97 0.99 0.58 0.40 1.16
Dividend Paid and CapEx Coverage Ratio
32.02 123.76 2.37 1.67 -6.13
Capital Expenditure Coverage Ratio
32.02 123.76 2.37 1.67 -6.13
Operating Cash Flow Coverage Ratio
0.10 0.10 0.03 0.03 -0.14
Operating Cash Flow to Sales Ratio
0.12 0.12 0.05 0.05 -0.29
Free Cash Flow Yield
24.53%21.17%4.74%2.12%-9.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-15.54 -18.49 -6.77 -4.09 30.36
Price-to-Sales (P/S) Ratio
0.49 0.58 0.59 1.03 3.67
Price-to-Book (P/B) Ratio
2.42 2.88 3.80 6.90 8.04
Price-to-Free Cash Flow (P/FCF) Ratio
4.08 4.72 21.08 47.07 -10.83
Price-to-Operating Cash Flow Ratio
3.94 4.68 12.20 18.83 -12.60
Price-to-Earnings Growth (PEG) Ratio
-0.99 0.28 0.10 0.01 -0.28
Price-to-Fair Value
2.42 2.88 3.80 6.90 8.04
Enterprise Value Multiple
7.88 9.75K 38.20 -11.93 18.70
Enterprise Value
294.22M 321.67M 394.98M 638.79M 1.53B
EV to EBITDA
7.88 9.75K 38.20 -11.93 18.70
EV to Sales
0.98 1.07 1.18 1.61 4.17
EV to Free Cash Flow
8.09 8.65 42.29 73.42 -12.31
EV to Operating Cash Flow
7.84 8.58 24.48 29.37 -14.32
Tangible Book Value Per Share
-0.79 -0.80 -0.96 -0.98 -0.03
Shareholders’ Equity Per Share
0.48 0.48 0.42 0.45 1.13
Tax and Other Ratios
Effective Tax Rate
-0.60 -0.60 0.02 0.02 0.02
Revenue Per Share
2.36 2.38 2.70 3.02 2.48
Net Income Per Share
-0.07 -0.08 -0.23 -0.76 0.30
Tax Burden
1.60 1.60 0.98 0.98 0.98
Interest Burden
-0.49 0.29 1.54 1.15 0.77
Research & Development to Revenue
0.02 0.02 0.02 0.03 0.02
SG&A to Revenue
0.39 0.39 0.38 0.33 0.29
Stock-Based Compensation to Revenue
0.08 0.00 0.08 0.06 0.08
Income Quality
-3.95 -3.95 -0.55 -0.22 -2.40
Currency in USD